Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	101227
Country	Portugal

Received	2024-09-08 11:21
Peer-Review Started	2024-09-08 11:21
To Make the First Decision
Return for Revision	2025-03-04 01:42
Revised	2025-03-16 22:41
Second Decision	2025-03-26 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-03-26 06:47
Articles in Press	2025-03-26 06:47
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-04-03 02:38
Typeset the Manuscript	2025-08-07 06:23
Publish the Manuscript Online	2025-08-25 12:36

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Editorial
Article Title	Predicting early recurrence in resectable rectal cancer
Manuscript Source	Invited Manuscript
All Author List	Manuel Carmo Silva, Tiago Correia de Sá, Kayla P Pereira and Joana M Pisco
ORCID	Author(s) ORCID Number Manuel Carmo Silva http://orcid.org/0000-0002-4017-1918 Tiago Correia de Sá http://orcid.org/0000-0002-9850-2847 Joana M Pisco http://orcid.org/0000-0002-7440-1144
Funding Agency and Grant Number
Corresponding Author	Manuel Carmo Silva, MD, Department of Radiotherapy, ULS Santa Maria, Av. Prof. Egas Moniz MB, Lisbon 1649-028, Portugal. mj.oliveiracampos@gmail.com
Key Words	Resectable rectal cancer; Early recurrence; Chemoradiotherapy; Recurrence free survival; Advanced imaging; Molecular biomarkers
Core Tip	The identification of an 8-month cut-off to distinguish early recurrence (ER) from late recurrence in rectal cancer emphasizes the importance of targeted surveillance in this period. Factors such as advanced age, preoperative chemoradiotherapy, and longer hospital stays highlight patient subsets that require intensive follow-up. Enhanced surveillance protocols with advanced imaging and molecular biomarkers could better manage recurrence and define risk groups for ER, improving treatment strategies and therefore survival outcomes and patient’s quality of life.
Publish Date	2025-08-25 12:36
Citation	<p>Carmo Silva M, Correia de Sá T, Pereira KP, Pisco JM. Predicting early recurrence in resectable rectal cancer. <i>World J Gastrointest Surg</i> 2025; 17(8): 101227</p>
URL	https://www.wjgnet.com/1948-9366/full/v17/i8/101227.htm
DOI	https://dx.doi.org/10.4240/wjgs.v17.i8.101227

Full Article (PDF)	WJGS-17-101227-with-cover.pdf
Manuscript File	101227_Auto_Edited_070717.docx
Answering Reviewers	101227-answering-reviewers.pdf
Audio Core Tip	101227-audio.m4a
Conflict-of-Interest Disclosure Form	101227-conflict-of-interest-statement.pdf
Copyright License Agreement	101227-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	101227-non-native-speakers.pdf
Peer-review Report	101227-peer-reviews.pdf
Scientific Misconduct Check	101227-scientific-misconduct-check.png
Scientific Editor Work List	101227-scientific-editor-work-list.pdf
CrossCheck Report	101227-crosscheck-report.png
CrossCheck Report	101227-crosscheck-report.pdf